Latest statistics on England mortality data suggest systematic mis-categorisation of vaccine status and uncertain effectiveness of Covid-19 vaccination
On 17 Dec, 2021 By admin 0 Comments
Public Policy
How bad data quality can turn a simulation into a dissimulation that shapes the future
On 14 Dec, 2021 By admin 0 Comments
DSA ADS Course, 2022
Data Quality, Black Box Models, Bad Models, Origins of SARS-CoV-2, Epidemiology, Non-pharmaceutical Interventions, Mitigation Strategies, COVID19, Health Policy, Public Policy
Review data quality evaluations, bad model design, policy decision-making based on data science, black box models, unwarranted assumptions in models, and evidence based policy making with near real-time data.
Beyond Ads: Sequential Decision-Making Algorithms in Public Policy
On 13 Dec, 2021 By admin 0 Comments
December, 2021
Abstract
John Ioannidis - Where are we now with COVID19?
On 12 Dec, 2021 By admin 0 Comments
The Line Dividing Good & Evil
On 10 Dec, 2021 By admin 0 Comments
Bayesian hypothesis testing and hierarchical modelling of ivermectin effectiveness in treating Covid-19
On 4 Dec, 2021 By admin 0 Comments
Worldwide Bayesian Causal Impact Analysis of Vaccine Administration on Deaths and Cases Associated with COVID-19: A BigData Analysis of 145 Countries
On 23 Nov, 2021 By admin 0 Comments
Green Pass and COVID-19 Vaccine Booster Shots in Israel – A More ‘Realistic’ Empirical Assessment Analyzing the National Airport Data
On 19 Nov, 2021 By admin 0 Comments
Analysing Covid Vaccine Efficiency and Safety Statistics
On 18 Nov, 2021 By admin 0 Comments
Inhaled Corticosteroids for Outpatients with Covid-19: A Meta-Analysis
On 6 Nov, 2021 By admin 0 Comments
November, 2021
Abstract
The role of inhaled corticosteroids for outpatient COVID-19 is evolving. We meta-analyzed reported clinical trials and estimated probability of any effect and number needed to treat of 50 or 20 for symptom resolution by day 14 [100%, 99.8%, 93.1%] and hospitalization [88.6%, 72.7%, 26.3%] respectively.
Inhaled corticosteroids are widely available, inexpensive in most jurisdictions, have few reported severe side effects and are likely beneficial based on the total evidence to date.